Drugs Made In America Acquisition (DMII) Prepaid Assets (2024 - 2025)

Drugs Made In America Acquisition (DMII) reported Prepaid Assets of $25814.0 for Q4 2025, down 39.38% year-over-year from $42580.0 in Q4 2024, and up 72.09% quarter-over-quarter from $15000.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) Prepaid Assets (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has 2 years of Prepaid Assets data on file, last reported at $25814.0 in Q4 2025.

  • Prepaid Assets for Q4 2025 came in at $25814.0, down 39.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $25814.0 (down 39.38% YoY), and the FY2025 annual result was $25814.0, down 39.38% from the prior year.
  • Prepaid Assets grew to $25814.0 in Q4 2025 per DMII's latest filing, from $15000.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $42580.0 in Q4 2024 and troughed at $15000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn -
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn -
3 Berto Acquisition 311.56 Mn 311.56 Mn -
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn -
5 Centurion Acquisition 310.21 Mn 310.21 Mn -
6 WEN Acquisition 309.15 Mn 309.15 Mn -
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn -
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn -
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn -
10 Drugs Made In America Acquisition 129.34 Mn 129.34 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 25,814.00
Sep 30, 2025 15,000.00
Dec 31, 2024 42,580.00